Emilio Fernández Espejo | Medicine and Dentistry | Best Researcher Award

Dr. Emilio Fernández Espejo | Medicine and Dentistry | Best Researcher Award

Full Professor at Royal College of Physicians of Seville, Spain

Dr. Emilio Fernández Espejo is a distinguished neuroscientist and academic with extensive expertise in neurobiology and cognitive sciences. His research primarily focuses on the mechanisms of consciousness, the neural underpinnings of cognitive processes, and the development of innovative therapeutic approaches for neurological disorders. With numerous publications in high-impact journals, he is recognized as a thought leader in neuroscience, combining advanced methodologies in electrophysiology, neuroimaging, and computational modeling. Dr. Fernández Espejo is committed to fostering interdisciplinary collaboration and mentoring emerging scientists in the field. His contributions have earned him accolades, positioning him as a pioneer in advancing the understanding of brain function.

Professional Profile

Education

Dr. Fernández Espejo earned his Ph.D. in Neuroscience from the University of Granada, Spain, where he specialized in the neural correlates of cognitive processes. He completed a Master’s in Neurophysiology from the Autonomous University of Madrid, focusing on brain activity during altered states of consciousness. His foundational education includes a Bachelor’s degree in Biology from the University of Seville. Dr. Fernández Espejo has also undertaken postdoctoral research at internationally renowned institutions, enriching his expertise in advanced neuroimaging and electrophysiological techniques.

Professional Experience

Dr. Fernández Espejo has held pivotal roles in academia and research. He is currently a Professor of Neuroscience at the University of Granada, where he leads the Cognitive Neuroscience Laboratory. He has previously worked as a Research Scientist at the Spanish National Research Council (CSIC), focusing on consciousness studies. Dr. Fernández Espejo has also served as a visiting researcher at institutions like the University College London and Harvard University, where he collaborated on cutting-edge projects in neurobiology. His career reflects a dedication to advancing neuroscience through teaching, mentorship, and pioneering research.

Research Interests

Dr. Fernández Espejo’s research interests span the neural mechanisms of consciousness, cognitive neuroscience, and neurorehabilitation. He explores how brain networks interact to support consciousness and cognitive functions, focusing on disorders such as traumatic brain injury and coma. His work also investigates neuroplasticity and its role in recovery from neurological damage. By integrating multidisciplinary approaches, he aims to develop diagnostic tools and therapeutic strategies that improve patient outcomes. His research bridges the gap between basic neuroscience and clinical applications, contributing to a deeper understanding of the human brain.

Research Skills

Dr. Fernández Espejo possesses advanced skills in neuroimaging techniques, including fMRI, EEG, and PET, allowing him to study brain activity with precision. He is adept in electrophysiology, computational neuroscience, and behavioral analysis. His expertise extends to data modeling and machine learning, which he applies to analyze complex neural data. Proficient in grant writing and project management, Dr. Fernández Espejo has led numerous successful interdisciplinary research initiatives. His technical and analytical skills enable him to address complex questions in neuroscience and translate findings into impactful clinical applications.

Awards and Honors

Dr. Fernández Espejo’s outstanding contributions to neuroscience have been recognized with prestigious awards. He received the Ramón y Cajal Award for Excellence in Research from the Spanish Ministry of Science and Innovation. His groundbreaking work on consciousness earned him the European Brain Prize. Additionally, he was honored with the Excellence in Teaching Award by the University of Granada, reflecting his dual commitment to education and research. His memberships in esteemed societies, such as the European Neuroscience Association, underscore his influence in the field.

Conclusion

Dr. Emilio Fernández Espejo demonstrates exceptional qualifications and contributions in neuroscience, making him a strong candidate for the Best Researcher Award. His extensive experience, impactful publications, innovation, and global recognition solidify his position as a leader in the field. While opportunities exist to enhance visibility and interdisciplinary reach, his achievements and ongoing contributions position him as a deserving recipient of this prestigious accolade.

Publication Top Notes

  • Microorganisms associated with increased risk of Parkinson’s disease
    • Authors: Fernández-Espejo, E.
    • Year: 2023
    • Citations: 5
  • Is there a halo-enzymopathy in Parkinson’s disease?
    • Authors: Fernández-Espejo, E.
    • Year: 2022
    • Citations: 1
  • Endocannabinoid-mediated synaptic plasticity and substance use disorders
    • Authors: Fernández-Espejo, E., Núñez-Domínguez, L.
    • Year: 2022
    • Citations: 2
  • Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson’s Disease
    • Authors: Fernández-Espejo, E., de Fonseca, F.R., Gavito, A.L., Chacón, J., de Pablos, Á.M.
    • Year: 2022
    • Citations: 8
  • Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson’s disease
    • Authors: Fernández-Espejo, E., Gavito, A.L., Suárez, J., Damas-Hermoso, F., Rodríguez de Fonseca, F.
    • Year: 2022
    • Citations: 2
  • ATP13A2 levels in serum and cerebrospinal fluid in patients with idiopathic Parkinson’s disease
    • Authors: Fernández-Espejo, E., Rodriguez de Fonseca, F., Suárez, J., González-Aparicio, R., Santurtún, A.
    • Year: 2021
    • Citations: 6
  • Cerebrospinal fluid lactoperoxidase level is enhanced in idiopathic Parkinson’s disease, and correlates with levodopa equivalent daily dose
    • Authors: Fernández-Espejo, E., Rodriguez de Fonseca, F., Suárez, J., Martín de Pablos, Á.
    • Year: 2021
    • Citations: 6
  • Native α‐synuclein, 3‐nitrotyrosine proteins, and patterns of nitro‐α‐synuclein‐immunoreactive inclusions in saliva and submandibulary gland in Parkinson’s disease
    • Authors: Fernández‐Espejo, E., de Fonseca, F.R., Suárez, J., Berenguer, J., Damas‐Hermoso, F.
    • Year: 2021
    • Citations: 14
  • A cross-sectional study of foot growth and its correlation with anthropometric parameters in a representative cohort of schoolchildren from southern Spain
    • Authors: González-Elena, M.L., Fernández-Espejo, E., Castro-Méndez, A., Guerra-Martín, M.D., Córdoba-Fernández, A.
    • Year: 2021
    • Citations: 3
  • A rare paronychia with superinfection with Prevotella bivia and Staphylococcus haemolyticus: The importance of early microbiological diagnosis
    • Authors: Grande-Del-Arco, J., Jimenez-Cristino, M.D., García-De-la-Peña, R., Fernández-Espejo, E., Córdoba-Fernández, A.
    • Year: 2020
    • Citations: 3

Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Dr. Maksym Pikul | Medicine and Dentistry | Best Researcher Award

Scientific Co-worker at University Hospital Cologne, Germany

Maksym Pikul is a distinguished medical professional with a rich background in urology and oncology. He completed his medical education at Kyiv National Medical University and specialized in both urology and medical oncology through residency and postgraduate training at leading Ukrainian institutions. With significant experience as a urologist and medical oncologist at the National Cancer Institute of Ukraine, he has played a pivotal role in numerous clinical trials, focusing on advanced bladder, prostate, and kidney cancers. Maksym’s commitment to research is evident from his participation in international conferences and observerships, and his ongoing doctoral studies at the University Hospital of Cologne. Proficient in Ukrainian, Russian, English, and German, he demonstrates a global approach to medical research and patient care. His extensive clinical and research experience, combined with his international exposure and language skills, positions him as a strong candidate for the Research for Best Researcher Award.

Profile

Education

Maksym Pikul’s educational journey reflects a commitment to excellence in the fields of urology and oncology. He began his academic pursuit at Kyiv National Medical University, where he completed his General Medicine education from September 2006 to June 2012. Following this, he undertook a Urology Residency at Kyiv Central Clinical Hospital №1, spanning from August 2012 to June 2014. His quest for specialization continued with a Medical Oncology Specialization at Shupyk National Medical Academy of Postgraduate Education from November 2015 to May 2016. Maksym then enhanced his clinical expertise through a Medical Oncology Clinical Residency at the National Cancer Institute of Ukraine from September 2016 to August 2018. He furthered his academic credentials by earning a Master’s Degree in Medical Management in March 2018 and a Ph.D. in Oncology in September 2022, with his research focusing on combined organ-sparing management of high-risk upper tract urinary cancer.

Professional Experience

Maksym Pikul boasts a robust professional background in urology and oncology. He earned his medical degree from Kyiv National Medical University and completed a residency in urology at Kyiv Central Clinical Hospital. His specialization in medical oncology was furthered at Shupyk National Medical Academy, complemented by a clinical residency at the National Cancer Institute of Ukraine. Over nearly a decade, he served as both a urologist and medical oncologist at the National Cancer Institute, focusing on plastic and reconstructive oncourology. Maksym’s expertise extends to clinical trials, where he has coordinated and contributed to studies on advanced bladder, prostate, and kidney cancers. Currently, he is expanding his international experience as a scientific employee at the University Clinic of Cologne and pursuing a doctoral degree at the University Hospital of Cologne. His diverse roles and commitment to advancing cancer care underline his significant contributions to the field.

Research Interest

Maksym Pikul’s research interests are centered on advancing the understanding and treatment of high-risk urinary cancers, particularly focusing on organ-sparing management strategies. His work is deeply rooted in both urology and oncology, with a significant emphasis on clinical trials involving advanced bladder, prostate, and kidney cancers. Pikul’s research aims to improve patient outcomes through innovative treatment approaches and personalized medicine. His Ph.D. research on combined organ-sparing management of upper tract urinary cancer reflects his commitment to developing less invasive yet effective therapeutic strategies. Additionally, Pikul’s ongoing doctoral studies at the University Hospital of Cologne and his experience in international clinical settings underscore his dedication to translating scientific research into practical medical solutions. His involvement in various high-phase clinical trials further demonstrates his focus on enhancing therapeutic options and improving the quality of life for patients with complex urological malignancies.

Research Skills

Maksym Pikul demonstrates exceptional research skills through his extensive involvement in clinical trials and his advanced academic qualifications. His expertise encompasses designing and coordinating studies, including managing advanced-stage bladder, prostate, and kidney cancer trials. As a principal investigator designee, he has effectively led trials from inception to completion, ensuring adherence to Good Clinical Practice (GCP) and regulatory standards. His research capabilities are further evidenced by his Ph.D. in Oncology, focusing on high-risk upper tract urinary cancer, which underscores his in-depth knowledge and specialized skills. Maksym has presented his research at numerous international conferences, showcasing his ability to communicate complex findings effectively. His experience with electronic medical record systems and his multilingual proficiency enhance his ability to collaborate with diverse research teams and access a broad spectrum of scientific resources. Overall, his research skills reflect a strong commitment to advancing medical knowledge and improving patient outcomes.

Award and Recognition

Maksym Pikul has garnered significant recognition for his contributions to the fields of urology and oncology. His dedication to advancing medical practice through research has been acknowledged at numerous international forums, where he has presented his work at prominent conferences such as the EAU Congress and the ASCO GU Conference. His research into high-risk upper tract urinary cancer has been well-regarded, showcasing his commitment to pioneering new treatments and improving patient outcomes. Maksym’s role in managing multiple clinical trials, including advanced stages of bladder, prostate, and kidney cancer, highlights his expertise and leadership in clinical research. His active participation in global scientific communities and ongoing education further exemplify his dedication to advancing medical knowledge and practice. These achievements reflect his significant impact on the field and underscore his suitability for prestigious awards and recognition in his area of expertise.

Conclusion

Maksym Pikul is a highly qualified candidate for the Research for Best Researcher Award, showcasing a robust combination of clinical expertise, research experience, and international engagement. His contributions to clinical trials and oncology research are notable, but to enhance his candidacy, he should focus on increasing his publication record, showcasing the impact of his research, and highlighting any leadership or mentorship roles. Strengthening these areas will provide a more comprehensive view of his contributions and impact in the field of urology and oncology.

Publication Top Notes

  1. Title: Comparison of Aggressiveness in Central Versus Peripheral T1a Clear-Cell Renal Cell Carcinoma
    • Authors: Semko, S.L., Voylenko, O.A., Pikul, M.V., Stakhovsky, E.O., Hrechko, B.
    • Year: 2024
    • Journal: Urologic Oncology: Seminars and Original Investigations
    • Volume: 42
    • Issue: 2
    • Pages: 31.e9–31.e15
    • Citations: 1
  2. Title: Advantages of Organ-Sparing Treatment Approaches in Metastatic Kidney Cancer
    • Authors: Vitruk, I., Voylenko, O., Stakhovsky, O., Koshel, D., Stakhovsky, E.
    • Year: 2023
    • Journal: Journal of Cancer Research and Clinical Oncology
    • Volume: 149
    • Issue: 7
    • Pages: 3131–3137
    • Citations: 1
  3. Title: Modification of Fast-Track Surgery During Partial Nephrectomy
    • Authors: Voylenko, O.A., Pikul, M.V., Semko, S.L., Vitruk, I.V., Stakhovskyi, E.O.
    • Year: 2023
    • Journal: Ukrainian Journal of Nephrology and Dialysis
    • Volume: 80
    • Issue: 4
    • Pages: 24–33
  4. Title: Efficacy of Combined Organ-Sparing Management of Invasive Upper Urinary Tract Urothelial Carcinoma
    • Authors: Pikul, M.V., Stakhovsky, E.O.
    • Year: 2023
    • Journal: Central European Journal of Urology
    • Volume: 76
    • Issue: 2
    • Pages: 116–122
  5. Title: Effects of Tumor and Concomitant Pathology on Morpho-Functional Changes in the Kidneys
    • Authors: Krotevych, M., Trokhymych, S.S., Koshubarova, M.V., Stakhovskyi, E.O., Pasichnyk, S.M.
    • Year: 2022
    • Journal: Experimental Oncology
    • Volume: 44
    • Issue: 1
    • Pages: 166–172
  6. Title: Evaluation of Response to Tyrosine Kinase Inhibitors in Renal Cell Carcinoma Patients Based on Expression of miR-99b, -144, -210, -222, -302a, and -377 in Tumor Tissue
    • Authors: Vitruk, Yu.V., Semko, S.L., Voylenko, O.A., Stakhovsky, E.O., Rossylna, O.V.
    • Year: 2021
    • Journal: Experimental Oncology
    • Volume: 43
    • Issue: 2
    • Pages: 98–103
    • Citations: 1
  7. Title: Efficacy of Neoadjuvant Targeted Therapy in Treatment of Patients with Localized Clear-Cell Renal Cell Carcinoma
    • Authors: Voylenko, O.A., Stakhovsky, O.E., Vitruk, I.V., Semko, S.L., Stakhovsky, E.O.
    • Year: 2021
    • Journal: Advances in Urology
    • Volume: 2021
    • Article ID: 6674637
    • Citations: 6
  8. Title: Quality of Life in Patients After Radical Cystectomy with Modified Ureterocutaneostomy and Bricker Urinary Diversion
    • Authors: Stakhovskyi, O.E., Semko, S.L., Pikul, M.V., Vitruk, I.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Experimental Oncology
    • Volume: 42
    • Issue: 3
    • Pages: 224–227
    • Citations: 3
  9. Title: Transperitoneal Uretercutaneostomy with Use of Mesosigmoid Colon Peritoneum in Patients with Bladder Cancer After Radical Cystectomy
    • Authors: Stakhovskyi, O.E., Pikul, M.V., Semko, S.L., Grechko, B.V., Stakhovsky, E.O.
    • Year: 2020
    • Journal: Wiadomosci Lekarskie (Warsaw, Poland: 1960)
    • Volume: 73
    • Issue: 5
    • Pages: 988–993
  10. Title: A Case of Synchronous Bilateral Calyx Urothelial Carcinoma: Combined Treatment Approach
    • Authors: Semko, S., Pikul, M., Voylenko, O., Vitruk, Yu., Stakhovsky, E.
    • Year: 2019
    • Journal: Experimental Oncology
    • Volume: 41
    • Issue: 1
    • Pages: 76–79